Acoustic Neuroma
Acoustic
neuromas are benign tumors that grow on
the nerve for hearing and balance. The
nerve for hearing and balance is more
properly called the vestibulocochlear
nerve or the eighth cranial nerve. This
nerve exits from the brainstem along
with the facial nerve (seventh cranial
nerve) and travels through the
cerebellopontine angle to enter the
internal auditory canal. The
vestibulocochlear nerve then divides
into a cochlear portion, which enters
the cochlea and carries hearing, and a
vestibular portion, which enters the
labyrinth and carries balance
information. Acoustic neuromas should
more properly be called vestibular
schwannomas since they arise from the
Schwann cells (cells that cover nerves
in the central nervous system) and occur
most commonly on the vestibular portion
of the vestibulocochlear (eighth cranial
nerve).
These tumors
are rare. They occur in 1 person per
100,000 people per year. These tumors
can occur either sporadically or as part
of an inherited disorder. The sporadic
tumors happen on only one side. The
inherited disorder is associated with
bilateral acoustic neuromas or a
unilateral acoustic neuroma along with
other brain or nerve tumors. This
inherited disorder is called
neurofibromatosis type 2, or NF-2; and
is inherited in an autosomal dominant
trait. Both NF-2 and sporadic cases of
acoustic neuromas are associated with an
abnormality on chromosome 22.
The most common
symptom of acoustic neuroma is hearing
loss. This hearing loss is usually a
unilateral, slowly progressive
sensorineural hearing loss. However,
some patients experience a sudden (<3
days) onset of hearing loss; and yet
other patients have little or no hearing
loss. On
audiometric
testing,
pure tone hearing, speech discrimination
and/or loss of acoustic reflexes might
signify the presence of an acoustic
neuroma.
Along with
unilateral hearing loss, a ringing sound
(also called tinnitus) in one ear is a
common symptom of an acoustic neuroma.
However, acoustic neuromas do not
produce a characteristic tinnitus. This
tinnitus is usually a constant sound in
just one ear that has been present for
more than two months.
Although these
tumors occur on the vestibular portion
of the eighth nerve, vertigo is an
uncommon symptom of acoustic neuromas.
More often, patients complain of an
off-balance sensation, especially if
turning quickly. It is theorized that
since these tumors grow slowly that the
brain compensates for the unilateral
vestibular loss nearly simultaneously.
Vestibular testing (ENG)
can sometimes show the vestibular loss
due to an acoustic neuroma.
Since the
facial nerve travels with the
vestibulocochlear nerve into the
internal auditory canal, facial
paralysis might occur as these tumors
grow larger and larger (>3 cm).
Other symptoms of
acoustic neuroma are headache, blurred
vision, numbness of the face,
hydrocephalus, or even death (if allowed
to grow unchecked). These symptoms
usually do not occur until the tumors
have reached a large size (>4 cm).
Although these
symptoms are found in patients with
acoustic neuromas, none are specific
enough to diagnose a tumor. An
audiogram is a necessary test in the
evaluation of these symptoms and is an
essential step in diagnosing an acoustic
neuroma. If there is a significant
amount of hearing loss or other symptoms
to suggest an acoustic neuroma, then an
ABR (auditory
brainstem response)
might be used to evaluate further the
reason for the hearing loss.
ABR is a
sensitive test for picking up tumors
that are larger than 1 cm in size.
Smaller tumors might escape detection
with ABR alone. Abnormal ABR findings
demand further evaluation by MRI.
Ultimately, an
MRI (magnetic resonance imaging) with
Gadolinium contrast is required to
diagnose these tumors.
This
type of imaging study gives an exquisite
view of the brain and the cranial
nerves. In patients with an acoustic
neuroma, the gadolinium contrast is
picked up by the tumor cells and makes
the tumor stand out from the surrounding
normal brain and nerve tissues. MRI can
pick up tumors that are as small as 1
mm. MRI scans permit a means of
measuring the tumor's size, which can be
used to monitor the tumor's growth, if
desired.
CT (computerized
tomography) scans with contrast can be
used to evaluate patients who cannot
otherwise have MRI scanning. CT lacks
the fine detail found on MRI, but can
reliably demonstrate tumors larger than
1-2 cm.
In general,
treatment can be divided into three
options:
-
Surgery
-
Radiotherapy
-
Observation
The goal of
surgery is to remove completely the
tumor and preserve as much normal
function as possible. All of these
procedures are performed under general
anesthesia. During every procedure, the
function of the facial nerve is
monitored. In patients with measurable
hearing, hearing can be monitored using
intraoperative ABR. All patients will
spend the first night after surgery in
the surgical ICU. The patient is
transferred to a regular room as his or
her condition permits, usually on the
day following surgery. Patients should
plan on spending one week in the
hospital, but usually only 4 -5 days of
total hospitalization are required.
The choice of
surgical approach is based on several
factors: (1) size of the tumor, (2)
status of hearing, and (3) experience of
the surgeon. Other factors, such as
facial or other cranial nerve status and
patient preference, are also
considerations. The three surgical
approaches for removal of acoustic
neuromas each have their own advantages
and disadvantages:
-
Middle
cranial fossa approach
-
Retrosigmoid/suboccipital approach
-
Translabyrinthine approach
In this
approach, an incision is made in the
skin above and behind the ear. Next, a
small window of skull bone above the ear
is removed, and the dura of the temporal
lobe is elevated exposing the bone of
the middle cranial fossa. Using a
microscope and drill, this bone is
removed and the internal auditory canal
is exposed. The dura of the internal
auditory canal is incised, and the tumor
is exposed. The tumor is then separated
from the facial nerve and, possibly, the
cochlear nerve. The tumor is then
removed. The operative site is then
closed by using a small plug of muscle
and a bone graft in the middle fossa
defect. The window of bone, removed at
the start of the procedure, is replaced
and sometimes affixed with microsurgical
plates. The soft tissues are then
closed in layers. A sterile pressure
dressing is then applied.
Since this
procedure leaves the inner ear intact,
it is an approach for potential hearing
preservation.
This approach
goes through the bone behind the sigmoid
sinus (the large vein that drains blood
from that side of the brain) at the back
of the head (the occiput). Once the
skin and soft tissue over the skull is
opened, an opening in the occiput is
created. Using a microscope, the dura
is opened and the lateral lobe of the
cerebellum is moved toward the midline.
This movement exposes the tumor within
the cerebellopontine angle; and this
portion of the tumor is separated from
the facial nerve and removed.
Oftentimes, the tumor extends into the
internal auditory canal. Using a fine
drill, the bone of the canal is removed
and the remaining portion of tumor is
removed. A plug of soft tissue is used
to close the internal auditory canal.
The cerebellum is allowed to return to
its normal position and the dura
covering it is closed. The soft tissues
and skin are closed in layers, and a
sterile dressing is applied.
Since this
procedure leaves the inner ear intact,
it is an approach for potential hearing
preservation.
This approach
goes through the mastoid and the
labyrinth (the balance organs) in order
to expose the internal auditory canal
and the tumor. The skin is incised
about 4 cm behind the ear. The bone of
the mastoid and temporal bone is exposed
and opened using a high speed drill and
microscope. The facial nerve is
identified within the temporal bone and
preserved; the labyrinth is removed.
The bone of the internal auditory canal
and the posterior fossa is removed. The
dura covering these structures is
opened, exposing the tumor. The tumor
is separated from the facial nerve; the
vestibular nerves are divided, and the
tumor is removed. Once the tumor has
been removed, closure occurs by
harvesting a portion of fat from the
abdomen and using this tissue to plug
the hole in the dura. The soft tissues
and skin are then closed in layers,
followed by a sterile dressing.
Since this
procedure removes the inner ear, it is
not possible to save hearing in the
operated ear.
All surgical
procedures have potential problems and
expected outcomes. The most common
potential problems and outcomes will be
described as enumerated below:
-
Hearing
loss. Many patients with
acoustic neuromas already have
hearing loss. However, a small
number of patients have small tumors
(<1.5 cm) and good hearing. Hearing
preservation can be attempted by
using either the retrosigmoid
approach or the middle fossa
approach. Success rates of hearing
preservation, even in the best of
circumstances, however, are only
about 30%. Even more uncommon is
hearing improvement, although we
have operated on patients who
experienced this improvement.
Hearing loss from this surgery is
more often an expected outcome from
the surgery.
-
Dizziness. Due to the slow
growth of these tumors, many
patients have already adapted to the
loss vestibular input from the tumor
side. Regardless of the approach
taken, the loss of vestibular input
from surgery will be complete.
Young patients (those less than 65
years of age) will usually recover
their balance quickly (within one
month). Persistent imbalance can
occur and usually vestibular
rehabilitation will help to improve
the patient's balance.
-
Tinnitus.
This is a common symptom of acoustic
neuroma. Removing the tumor does
not necessarily change, improve, or
diminish the tinnitus. Even in
patient with hearing preservation
might continue to have tinnitus
following surgery. Most patients
seem to accommodate to this tinnitus
after the surgery.
-
Facial
paralysis. Avoiding facial
paralysis has been the major
advancement in acoustic neuroma
surgery over the last 10 - 15
years. The use of facial nerve
monitors has helped surgeons to
identify the facial nerve, and thus
preserve its function. Large tumors
(>3 cm in size) are harder to remove
and preserve facial function. Some
smaller tumors can be difficult to
separate from the facial nerve as
well, especially if the tumor is
hard and fibrous. If the nerve can
be anatomically preserved,
frequently its function will return
to near normal function. Facial
nerve grafts are sometimes performed
at the time of operation in patients
whose facial nerve cannot be saved.
Other techniques for facial
reanimation include the hypoglossal
to facial nerve graft, static facial
slings and gold weight eyelid
implants. Please look at the
facial
paralysis page
for more information regarding this
problem.
-
Cerebrospinal fluid leak. The
brain is surrounded by fluid, called
cerebrospinal fluid or CSF. Any
time the dura is opened, there is a
potential for leakage of CSF. Great
care is taken at the time of closure
to prevent this fluid from leaking
either out of the incision site, the
ear canal, or the nose (by way of
the Eustachian tube). Regardless of
technique, CSF leak seems to occur
in about 10% of cases. Treatment
for CSF leak can involve placing a
drain in the back (called a lumbar
drain) to remove spinal fluid and
allow the repair site to heal.
Sometimes additional surgical
procedures are necessary to stop the
fluid leak.
-
Meningitis. Meningitis is
inflammation or infection of the
coverings of the brain (the meninges).
Careful attention to sterile
technique and the use of peri-operative
antibiotics has minimized the
occurrence of meningitis to 1-4%.
If meningitis does occur, a spinal
fluid tap will be performed to find
the organism that is causing the
infection and to determine which
antibiotics will be most effective
at curing the infection.
-
Headache.
Headache following acoustic neuroma
surgery can be a sign of
meningitis. Sometimes, patients who
have had a retrosigmoid approach
will have headache that persists for
several months following surgery.
This headache is usually relieved by
NSAIDs.
-
Other
central nervous system complications,
such as stroke, seizure, and death,
have been reported in large surgical
series; however, their occurrence is
rare (<1%).
Radiation has
been used to treat acoustic tumors for
the past 20 or so years. This procedure
involves a special form of radiation
therapy using a device commonly called
the Gamma Knife. More properly, it is a
stereotactic radiotherapy that can
deliver more than 200 beams of radiation
directed to the tumor location. This
concentrated dose of focused radiation
energy can destroy tumor cells. This
procedure is done using local anesthesia
and sedation and is performed on an
outpatient basis. There is only one
treatment given.
The advantage
of this approach is the avoidance of
surgery, the period of hospitalization,
and the recovery period necessary
following surgery. Initially, hearing
preservation and facial nerve function
can be higher than surgery; however,
long term results are probably no
different than that for surgery.
The
disadvantage of this approach is
manifold. Although the radiation does
kill some tumor cells, it does not kill
all cells, and it does not remove the
tumor.
The
remaining cells might grow, producing a
recurrent tumor. In those cases where a
recurrent tumor was surgically removed,
the procedure was technically more
difficult; and the post-operative facial
nerve function was poorer than in
surgical patients with equivalent sized
tumors without prior radiation therapy.
Facial nerve weakness or paralysis has
been reported after Gamma knife therapy
alone. Sometimes this is due to
swelling in the tumor following
radiation. Hearing loss does occur in
patients who have Gamma Knife therapy.
Sometimes this hearing loss occurs
suddenly after treatment or in several
months after treatment.
In general, we
have recommended Gamma Knife therapy to
patients who could not otherwise have
surgery and who did not have a large
tumor causing central nervous system
problems.
These tumors
are benign, meaning that they do not
spread throughout the body, and slow
growing. These patients undergo serial
MRI scans every 6 - 12 months, depending
on the tumor's rate of growth.
Observation of the tumor might be used
in patients that have very small tumors
and who are otherwise not good
candidates for the treatments listed
above (e.g. patients > 75 years of age
with complicating medical problems).
Surgery is usually required as tumors
grow out of the internal auditory canal
and into the cerebellopontine angle and
brainstem.
However, in
patients that are in good health, have
good hearing, and have small tumors (< 1
cm), surgery does offer the possibility
of complete removal with preservation of
hearing and facial nerve function.
Acoustic
neuromas are rare tumors that grow on
the vestibulocochlear nerve. The
symptoms of these tumors include hearing
loss, tinnitus, imbalance, facial nerve
weakness, headache, etc. Surgical
treatments are very successful at
removing tumors, and preserving facial
nerve function. Hearing preservation
can be attempted in appropriately
selected patients. Radiation therapy is
available to patients, especially those
who could not otherwise undergo
surgery. Some tumors are followed on
serial MRI examinations, especially in
elderly patients with small tumors.